Showing results (71-80 of 141) with videos related to

Sort By:
Pageof 15
Neurology|November 1, 1983
Treatment of polyneuropathy in Waldenström's macroglobulinemia: role of paraproteinemia and immunologic studiesM C Dalakas, M A Flaum, M Rick, et al.
The Journal of Experimental Medicine|September 1, 1993
The bone marrow of multiple myeloma patients contains B cell populations at different stages of differentiation that are clonally related to the malignant plasma cellD Billadeau, G Ahmann, P Greipp, et al.
The Journal of Biological Chemistry|May 25, 1986
Comparison of the specificities of laminin, thrombospondin, and von Willebrand factor for binding to sulfated glycolipidsD D Roberts, C N Rao, L A Liotta, et al.
American Journal of Hematology|February 1, 1996
1-Desamino-8-arginine-vasopressin corrects the hemostatic defects in type 2B von Willebrand's diseaseL P McKeown, G Connaghan, O Wilson, et al.
The Journal of Laboratory and Clinical Medicine|October 1, 1982
Quantification of acute phase reactants after muscle biopsyR J Elin, M Foidart, B T Adornato, et al.
The American Journal of Medicine|December 1, 1988
Plasma and platelet von Willebrand factor defects in uremiaH R Gralnick, L P McKeown, S B Williams, et al.
The Journal of Laboratory and Clinical Medicine|November 1, 1996
Glycoprotein Ib alpha peptides inhibit thrombin and SFLLRN-induced platelet aggregationL P McKeown, S B Williams, K E Hansmann, et al.
British Journal of Haematology|January 1, 1985
IgA inhibitor to factor VIII/von Willebrand factorH R Gralnick, M A Flaum, C M Kessler, et al.
Thrombosis and Haemostasis|April 2, 1992
The effect of suramin on laboratory tests of coagulationM K Horne, O J Wilson, M Cooper, et al.
American Journal of Hematology|March 1, 1987
A variant of type II von Willebrand disease with an abnormal triplet structure and discordant effects of protease inhibitors on plasma and platelet von Willebrand factor structureH R Gralnick, S B Williams, L P McKeown, et al.
Pageof 15